Gam-COVID-Vac
Russian viral vector vaccine based on human adenovirus
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, romanized: Gam-KOVID-Vak), trade-named Sputnik V, is a COVID-19 vaccine created by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health.[1][2][3]
Gam-COVID-Vac has been approved for distribution in Russia.[1][4][5]
References
change- ↑ 1.0 1.1 Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400.
This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
- ↑ Cohen J (11 August 2020). "Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. Retrieved 13 August 2020.
- ↑ Kelland K (11 August 2020). "Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?". Reuters. Retrieved 11 August 2020.
- ↑ Mahase E (August 2020). "Covid-19: Russia approves vaccine without large scale testing or published results". BMJ. 370: m3205. doi:10.1136/bmj.m3205. PMID 32816758.
- ↑ Bar-Zeev N, Inglesby T (September 2020). "COVID-19 vaccines: early success and remaining challenges". Lancet. 396 (10255): 868–869. doi:10.1016/S0140-6736(20)31867-5. PMC 7471800. PMID 32896290.
